Abstract

Background
Irritant-induced asthma (IIA) is a rare form of occupational asthma of which long-term outcome is poorly known.
 
Objective
To evaluate the long-term clinical outcome of patients with IIA.
 
Methods
We identified 69 patients diagnosed with IIA at the Finnish Institute of Occupational Health during 2004-2018. Twenty-eight of them participated in follow-up evaluation. Median interval since 1st exposure to causal agent was 11.0 years (IQR 6.5-15.6) for participants and 15.9 years (IQR 11.7-22.0) for non-participants. Otherwise, these groups appeared comparable.
 
Results

Variable Participants (N=28) P-value
Baseline Follow-up
Male 26 (93%) X X
Age
Mean (SD)
46 (10.7) 54 (9.5) X
BMI, kg/m2
Mean (SD)
28.7 (5.2) 30.4 (6.6) 0.014
Smoking of ?10 pack years 10 (36%) 11 (39%) 1.000
GINA 4-5 step asthma medication 12 (43%) 18 (64%) 0.754
Exacerbation ?1 year 8 (29%) 4 (15%) 0.375
Poor symptom control1 13 (76%) 11 (39%) 0.008
Non-specific bronchial hyperreactivity2 13 (46%) 8 (36%) 0.508
FEV1% <80% 8 (29%) 6 (22%) 1.000
FeNO ?25ppb 8 (29%) 7 (25%) 1.000
B-Eos ?300u/l 5 (18%) 10 (36%) 0.125
Impaired exercise capacity in bicycle ergometry3 X 15 (58%) X
Score of <17.1 in Newcastle laryngeal hypersensitivity questionnaire X 6 (23%) X
Dysfunctional breathing4 X 7 (26%) X

1Asthma Control Test score of ?19 represented poor symptom control. Seventeen participants took the test at baseline
225 and 22 participants took the test, respectively
3Values of Wmax4%? 80% represented normal exercise capacity
4Score of ?23 in Nijmegen questionnaire

Conclusions

In the long-term follow-up, patients with IIA need frequently intensive medication and show poor exercise capacity. Majority of them have normal lung functions and asthma control appears to improve by time.